Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Kidney Injury | 5 | 2017 | 146 | 1.560 |
Why?
|
| Cardio-Renal Syndrome | 3 | 2018 | 8 | 1.080 |
Why?
|
| Heart Failure | 4 | 2018 | 915 | 1.060 |
Why?
|
| Diuretics | 3 | 2013 | 62 | 0.840 |
Why?
|
| Hyponatremia | 2 | 2010 | 13 | 0.560 |
Why?
|
| Ultrafiltration | 2 | 2013 | 13 | 0.500 |
Why?
|
| Renal Artery Obstruction | 1 | 2014 | 19 | 0.440 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2014 | 25 | 0.440 |
Why?
|
| Hemofiltration | 1 | 2013 | 18 | 0.420 |
Why?
|
| Patient Readmission | 1 | 2017 | 430 | 0.390 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2012 | 8 | 0.390 |
Why?
|
| Acetylcysteine | 1 | 2012 | 27 | 0.390 |
Why?
|
| Risk Assessment | 2 | 2017 | 2076 | 0.380 |
Why?
|
| Nephritis, Interstitial | 1 | 2011 | 15 | 0.370 |
Why?
|
| Kidney | 3 | 2011 | 447 | 0.360 |
Why?
|
| Vasculitis | 1 | 2011 | 51 | 0.360 |
Why?
|
| Sarcoidosis | 1 | 2011 | 34 | 0.360 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2010 | 3 | 0.350 |
Why?
|
| Kidney Diseases | 1 | 2011 | 177 | 0.330 |
Why?
|
| Stents | 1 | 2014 | 491 | 0.330 |
Why?
|
| Contrast Media | 1 | 2012 | 425 | 0.330 |
Why?
|
| Myocardial Ischemia | 2 | 2011 | 118 | 0.270 |
Why?
|
| Natriuretic Peptides | 1 | 2006 | 9 | 0.250 |
Why?
|
| Renal Insufficiency | 1 | 2006 | 66 | 0.250 |
Why?
|
| Creatinine | 2 | 2017 | 136 | 0.220 |
Why?
|
| Troponin T | 1 | 2002 | 25 | 0.200 |
Why?
|
| Troponin I | 1 | 2002 | 36 | 0.200 |
Why?
|
| Humans | 15 | 2018 | 63299 | 0.190 |
Why?
|
| Fluid Therapy | 2 | 2012 | 49 | 0.180 |
Why?
|
| Male | 9 | 2017 | 29823 | 0.180 |
Why?
|
| Kidney Failure, Chronic | 1 | 2002 | 205 | 0.170 |
Why?
|
| Water-Electrolyte Balance | 2 | 2012 | 17 | 0.160 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 834 | 0.150 |
Why?
|
| Inappropriate ADH Syndrome | 2 | 2010 | 7 | 0.140 |
Why?
|
| Kidney Function Tests | 1 | 2017 | 38 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 2 | 2012 | 734 | 0.130 |
Why?
|
| Risk Factors | 3 | 2017 | 5343 | 0.130 |
Why?
|
| Renal Dialysis | 2 | 2012 | 198 | 0.130 |
Why?
|
| Female | 7 | 2017 | 32793 | 0.130 |
Why?
|
| Comorbidity | 2 | 2011 | 1122 | 0.120 |
Why?
|
| Acute Disease | 1 | 2017 | 672 | 0.120 |
Why?
|
| Survival Rate | 1 | 2017 | 850 | 0.110 |
Why?
|
| Incidence | 1 | 2017 | 1376 | 0.100 |
Why?
|
| Blood Volume | 1 | 2012 | 42 | 0.100 |
Why?
|
| Administration, Intravenous | 1 | 2012 | 66 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2012 | 5655 | 0.100 |
Why?
|
| Anaphylaxis | 1 | 2012 | 40 | 0.100 |
Why?
|
| Peritoneal Dialysis | 1 | 2011 | 14 | 0.090 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2011 | 13 | 0.090 |
Why?
|
| Time Factors | 2 | 2017 | 3762 | 0.090 |
Why?
|
| Furosemide | 1 | 2011 | 21 | 0.090 |
Why?
|
| Prednisone | 1 | 2011 | 86 | 0.090 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2011 | 44 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 2457 | 0.090 |
Why?
|
| Potassium | 1 | 2011 | 101 | 0.090 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 174 | 0.090 |
Why?
|
| Glomerular Filtration Rate | 1 | 2011 | 113 | 0.090 |
Why?
|
| Antidiuretic Hormone Receptor Antagonists | 1 | 2010 | 3 | 0.090 |
Why?
|
| Demyelinating Diseases | 1 | 2010 | 16 | 0.090 |
Why?
|
| Extracellular Fluid | 1 | 2010 | 11 | 0.090 |
Why?
|
| Aged | 4 | 2017 | 14396 | 0.090 |
Why?
|
| Sodium | 1 | 2010 | 62 | 0.080 |
Why?
|
| Osmolar Concentration | 1 | 2010 | 89 | 0.080 |
Why?
|
| Brain Edema | 1 | 2010 | 31 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2011 | 188 | 0.080 |
Why?
|
| Biopsy | 1 | 2011 | 444 | 0.080 |
Why?
|
| Fibrosis | 1 | 2010 | 160 | 0.080 |
Why?
|
| Length of Stay | 1 | 2011 | 811 | 0.070 |
Why?
|
| Retrospective Studies | 1 | 2017 | 6635 | 0.060 |
Why?
|
| Body Water | 1 | 2004 | 16 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2006 | 131 | 0.060 |
Why?
|
| United States | 1 | 2017 | 7826 | 0.050 |
Why?
|
| Creatine Kinase | 1 | 2002 | 42 | 0.050 |
Why?
|
| Ileum | 1 | 2002 | 22 | 0.050 |
Why?
|
| Peyer's Patches | 1 | 2002 | 36 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 1146 | 0.040 |
Why?
|
| Middle Aged | 3 | 2012 | 17556 | 0.040 |
Why?
|
| Biomarkers | 1 | 2002 | 1397 | 0.030 |
Why?
|
| Blood Volume Determination | 1 | 2012 | 3 | 0.020 |
Why?
|
| Arterial Pressure | 1 | 2012 | 27 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2012 | 330 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2012 | 269 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2012 | 406 | 0.020 |
Why?
|
| Critical Illness | 1 | 2012 | 322 | 0.020 |
Why?
|
| Critical Care | 1 | 2012 | 397 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2012 | 3283 | 0.010 |
Why?
|
| Adult | 2 | 2012 | 16788 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2002 | 111 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 1120 | 0.010 |
Why?
|
| Age Factors | 1 | 2002 | 1558 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 5452 | 0.010 |
Why?
|
| Adolescent | 1 | 2002 | 6241 | 0.010 |
Why?
|